RTI Surgical Inc. (RTIX)

4.65
NASDAQ : Health Technology
Prev Close 4.60
Day Low/High 4.40 / 4.65
52 Wk Low/High 3.30 / 6.00
Avg Volume 146.20K
Exchange NASDAQ
Shares Outstanding 60.83M
Market Cap 267.66M
EPS -0.30
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

RTI Surgical Outlines 2018 Guidance And Long-Term Goals

RTI Surgical Outlines 2018 Guidance And Long-Term Goals

RTI Surgical, Inc. (Nasdaq:RTIX), a global surgical implant company, today outlined its 2018 guidance and long-term financial goals.

RTI Surgical Announces Acquisition Of Zyga Technology, Inc.

RTI Surgical Announces Acquisition Of Zyga Technology, Inc.

RTI Surgical, Inc. (Nasdaq: RTIX), a global surgical implant company, today signed an agreement to acquire Zyga Technology, Inc.

RTIX: Insiders vs. Shorts

The most recent short interest data was recently released for the 11/30/2017 settlement date, and RTI Surgical, Inc. is one of the most shorted stocks of the Russell 3000, based on 7.31 "days to cover" versus the median component at 5.11.

RTI Surgical® Announces 2017 Third Quarter Results

RTI Surgical® Announces 2017 Third Quarter Results

RTI Surgical Inc. (RTI) (Nasdaq: RTIX), a global surgical implant company, reported operating results for the third quarter, ended September 30, 2017.

RTI Surgical® Schedules 2017 Third Quarter Earnings Call For November 2, 2017

RTI Surgical® Schedules 2017 Third Quarter Earnings Call For November 2, 2017

RTI Surgical Inc. (RTI) (Nasdaq: RTIX), a global surgical implant company, today announced that it plans to release financial results from the third quarter 2017 on Thursday, November 2, 2017 prior to the market open.

Fortilink-C IBF System (Photo: Business Wire)

Fortilink-C IBF System (Photo: Business Wire)

RTI Surgical, Inc. (RTI) (Nasdaq: RTIX), a global surgical implant company, today announced the commercial launch of Fortilink-C IBF System with TETRAfuse ® 3D Technology.

RTI Surgical® Introduces TETRAfuse® 3D Technology Becoming First To Offer 3D Printed Interbody Polymer Optimized To Participate In Fusion

RTI Surgical® Introduces TETRAfuse® 3D Technology Becoming First To Offer 3D Printed Interbody Polymer Optimized To Participate In Fusion

RTI Surgical, Inc. (RTI) (Nasdaq: RTIX), a global surgical implant company, today announced the introduction of TETRAfuse ® 3D Technology, providing surgeons a solution they have been seeking.

RTI Surgical® Continues To Augment Leadership Team To Accelerate Its Strategic Direction

RTI Surgical® Continues To Augment Leadership Team To Accelerate Its Strategic Direction

RTI Surgical Inc. (RTI) (Nasdaq:RTIX), a leading global surgical implant company, announced today three new appointments to its senior leadership team to accelerate the Company's strategic growth initiatives.

RTIX: Insiders Vs. Shorts

RTIX: Insiders Vs. Shorts

The most recent short interest data was recently released for the 08/31/2017 settlement date, and RTI Surgical, Inc. is one of the most shorted stocks of the Russell 3000, based on 9.03 "days to cover" versus the median component at 6.19.

RTI Surgical Becomes Oversold (RTIX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

RTI Surgical® Announces 2017 Second Quarter Results

RTI Surgical® Announces 2017 Second Quarter Results

RTI Surgical Inc. (RTI) (Nasdaq: RTIX), a global surgical implant company, reported operating results for the second quarter of 2017.

RTI Surgical® Divests Cardiothoracic Closure Business To A&E Medical Corporation For Up To $60 Million

RTI Surgical® Divests Cardiothoracic Closure Business To A&E Medical Corporation For Up To $60 Million

RTI Surgical Inc. (RTI) (Nasdaq: RTIX), a global surgical implant company, today announced that it has sold its cardiothoracic closure business to A&E Advanced Closure Systems, LLC (A&E Medical), a leading...

RTI Surgical® Schedules 2017 Second Quarter Earnings Call For August 8, 2017

RTI Surgical® Schedules 2017 Second Quarter Earnings Call For August 8, 2017

RTI Surgical Inc. (RTI) (Nasdaq: RTIX), a global surgical implant company, announced today that it plans to release financial results from the second quarter 2017 on Tuesday, August 8, 2017, prior to the market open.

Commit To Purchase RTI Surgical At $5, Earn 22.7% Annualized Using Options

Investors eyeing a purchase of RTI Surgical, Inc. stock, but tentative about paying the going market price of $5.15/share, might benefit from considering selling puts among the alternative strategies at their disposal.

RTIX: Insiders vs. Shorts

The most recent short interest data was recently released for the 05/15/2017 settlement date, and RTI Surgical, Inc. is one of the most shorted stocks of the Russell 3000, based on 5.64 "days to cover" versus the median component at 4.71.

Integra's Massive Run-Up Expected to Continue as J&J's Surgical Business Joins the Fold

Integra's Massive Run-Up Expected to Continue as J&J's Surgical Business Joins the Fold

Integra announced in February its intent to acquire Codman Neurosurgery from Johnson & Johnson.

RTI Surgical® Partners In New Manufacturing USA Institute

RTI Surgical (RTI) (Nasdaq: RTIX), a global surgical implant company, is part of a new public-private Manufacturing USA initiative, the Advanced Regenerative Manufacturing Institute (ARMI).

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AOSL, AVD, BCC, BGSF, CDR, CTRE, DV, LUK, PHX, PRLB, RTIX, SFM, STAY, TRP, WAGE, ZAGG Downgrades: ABCO, ACIW, AMAG, CQP, HDNG, INT, NEWM, RGS, SGEN, SSP, TAC Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

RTI Surgical® Announces 2017 First Quarter Results

RTI Surgical Inc. (RTI) (Nasdaq: RTIX), a global surgical implant company, reported operating results for the first quarter of 2017.

RTI Surgical® Schedules 2017 First Quarter Earnings Call For April 27, 2017

RTI Surgical Inc. (RTI) (Nasdaq: RTIX), a global surgical implant company, announced today that it plans to release financial results from the first quarter 2017 on Thursday, April 27, 2017, prior to the market open.

RTI Surgical® Expands Line Of Matrices In International Markets

RTI Surgical Inc. (RTI) (Nasdaq: RTIX), a global surgical implant company, is pleased to announce the expansion of its extensive line of tissue matrices in international markets.

On the Trail of Insider Buying

Execs' activity directs us to 2 promising names.

RTI Surgical, Inc. And Krensavage Partners, LP Reach Settlement Agreement

RTI Surgical Inc. ("RTI") (Nasdaq:RTIX), a global surgical implant company, announced today that it has entered into a settlement agreement with an investor group led by Krensavage Partners, LP (collectively...

RTIX: Insiders vs. Shorts

The most recent short interest data was recently released for the 01/31/2017 settlement date, and RTI Surgical, Inc. is one of the most shorted stocks of the Russell 3000, based on 9.19 "days to cover" versus the median component at 5.13.

RTI Surgical® Announces 2016 Fourth Quarter, Full Year Results; Initiates Actions To Improve Execution And Return To Profitable Growth

RTI Surgical Inc. (RTI) (Nasdaq: RTIX), a global surgical implant company, reported operating results for the fourth quarter and full year of 2016.

RTI Surgical® Schedules 2016 Fourth Quarter, Year End Earnings And Conference Call For Feb. 23, 2017

RTI Surgical Inc. (RTI) (Nasdaq: RTIX), a global surgical implant company, announced today that it plans to release financial results from the fourth quarter and year ended December 31, 2016 on Thursday, Feb.

RTI Surgical® Makes An Inducement Grant To Camille Farhat, New Chief Executive Officer

RTI Surgical Inc. (RTI) (Nasdaq:RTIX), a global surgical implant company, announced today that it made an inducement grant to Camille Farhat.

RTI Surgical Names Camille Farhat Chief Executive Officer (Photo: Business Wire)

RTI Surgical Names Camille Farhat Chief Executive Officer (Photo: Business Wire)

RTI Surgical Inc. ("RTI" or "the company") (Nasdaq: RTIX), a leading global surgical implant company, today announced that Camille Farhat has been named chief executive officer, effective March 15, 2017.

TheStreet Quant Rating: C- (Hold)